Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.
| Image |  |
|---|---|
| Description | scientific article published in October 2004 |
| Author/s |
author: Jörg Beyer Francis Ayuk Jesús San Miguel |
| Publication date | October 1, 2004 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |